Romaric Tuono De Manfouo | Health Professions | Best Researcher Award

Mr. Romaric Tuono De Manfouo | Health Professions | Best Researcher Award

University of the Mountains | Cameroon

Mr. Romaric Tuono De Manfouo is an accomplished biomedical researcher specializing in hematology, infectious diseases, and public health. His work integrates laboratory investigations, epidemiological studies, and translational research to address pressing health challenges in sub-Saharan Africa. With a proven record of impactful scientific contributions, he has been involved in multidisciplinary projects exploring blood disorders, viral infections, and immunological responses. His ability to conduct rigorous clinical studies and collaborate with diverse research teams has positioned him as a respected figure in his field, committed to improving patient care through scientific advancement.

Professional Profile

Scopus

ORCID

Education

Mr. Romaric’s academic journey reflects a strong foundation in health sciences, with a focus on biomedical and clinical research. His studies provided comprehensive training in hematology, immunology, molecular biology, and epidemiology, allowing him to develop the expertise necessary to investigate complex medical conditions. Through extensive research training and practical exposure, he has acquired the skills to design and execute studies that address both laboratory-based and population-level health concerns.

Experience

Throughout his career, Mr. Romaric has worked in academic institutions, research laboratories, and collaborative health projects, contributing to knowledge generation and clinical decision-making. He has been a lead investigator and co-author on studies examining hematological profiles, hemostasis, infectious disease prevalence, and genetic conditions affecting blood health. His experience spans from advanced diagnostic testing to community-based data collection, making his work relevant to both clinical medicine and public health policy.

Research Interest

His research interests center on understanding the mechanisms and epidemiology of blood-related disorders such as sickle cell disease, glucose-6-phosphate dehydrogenase deficiency, and alloimmunization in chronic illness. He is equally engaged in studying infectious diseases including viral hepatitis and their impact on vulnerable populations such as pregnant women, newborns, and high-risk adult groups. His goal is to generate evidence that informs targeted interventions, improves early detection, and enhances patient outcomes in low-resource settings.

Awards

Mr. Romaric’s scientific achievements have been recognized through his publication record, invitations to review for international peer-reviewed journals, and collaborations with multidisciplinary research teams. His expertise is sought after in both academic and clinical research contexts, and his work continues to contribute to advancements in hematology, epidemiology, and public health.

Publications

  • Title: Abnormalities of Hemostasis in Sickle Cell Patients and Predisposition to Thrombotic Risk: A Systematic Review and Meta-Analysis
    Journal: Preprint
    Published on: 2025

  • Title: Inflammation and Iron Profile in Children With Sickle Cell Disease in Cameroon: Frequency and Associated Factors, an Analytical Cross‐Sectional Study
    Journal: Health Science Reports
    Published on: 2025

  • Title: Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon: Case–Control Study
    Journal: Health Science Reports
    Published on: 2025

  • Title: Cytopenias and Associated Factors in Patients Living With HIV on ARV Treatment in Cameroon: An Analytical Cross‐Sectional Study
    Journal: Advances in Hematology
    Published on: 2025

  • Title: Haptoglobin Gene Polymorphism and Iron Profile in Sickle Cell Disease Patients With Inflammation in Yaounde, Cameroon
    Journal: Molecular Genetics & Genomic Medicine
    Published on: 2024

  • Title: Hematological And Hemostasis Profile, Thrombotic Risk In Sickle Cell Patient In Cameroon: An Analytical Cross-Sectional Study
    Journal: Hematology and Disorders
    Published on: 2024

  • Title: Hyperuricemia and Associated Factors: The Case of Outpatients at the Bafoussam Regional Hospital-Cameroon, an Analytical Cross-Sectional Study
    Journal: Health Science Reports
    Published on: 2024

Conclusion

Mr. Romaric Tuono De Manfouo exemplifies excellence in biomedical research, combining academic rigor, clinical insight, and a commitment to public health. His body of work reflects a consistent focus on improving the understanding, diagnosis, and management of hematological and infectious diseases in African populations. Through his scholarly publications, peer-review contributions, and research leadership, he continues to make significant contributions that enhance scientific knowledge and healthcare delivery. His achievements make him a worthy nominee for the Best Researcher Award, representing dedication, innovation, and scientific integrity.

Shoukui Hu | Medicine and Health Sciences | Best Researcher Award

Dr. Shoukui Hu | Medicine and Health Sciences | Best Researcher Award

Zhengzhou Central Hospital Affiliated to Zhengzhou University | China

Dr. Shoukui Hu is a distinguished medical microbiologist and molecular biologist currently serving as the Director of the Clinical Laboratory and Blood Transfusion Department at Peking University Shougang Hospital. With over two decades of impactful work in pathogenic biology, Dr. Hu has been instrumental in advancing public health diagnostics and molecular epidemiology in China. His leadership and research contributions have strengthened clinical laboratory practices and disease surveillance.

Author Profile👤

ORCID

Scopus

Strengths for the Awards✨

Dr. Shoukui Hu brings over two decades of experience in pathogenic biology and molecular biology, having contributed significantly to public health and clinical research in China. He currently serves as the Director of the Clinical Laboratory and Blood Transfusion Department at Peking University Shougang Hospital, a role that highlights both his leadership capabilities and clinical expertise. His academic journey, culminating in a Ph.D. from the China CDC, laid a solid foundation for impactful research in infectious diseases, microbiology, and translational diagnostics.

A standout strength is his strong publication record, with at least nine peer-reviewed SCI-indexed articles published in the past five years alone—many as corresponding or first author. These papers cover emerging infectious pathogens such as Candida auris, Helicobacter pylori, Neisseria meningitidis, and Streptococcus pneumoniae, which are critical topics in global public health. His research has been published in high-impact Q1 and Q2 journals such as Gut Microbes, Helicobacter, BMC Genomics, and World Journal of Gastroenterology, demonstrating relevance, innovation, and scientific rigor.

Furthermore, Dr. Hu’s expertise in molecular diagnostics, particularly the development of biosensors and amplification techniques, shows clear translational value, directly impacting clinical diagnostics and public health surveillance systems. His dual expertise in research and hospital management positions him as a bridge between science and clinical application—an invaluable trait for advancing healthcare innovations.

🎓 Education

Dr. Hu began his academic journey with a BSc from Anhui Science and Technology University (1995–1999), followed by an MSc in Microbiology (2001–2004) jointly awarded by the National Institute for Communicable Disease Control and Prevention and Anhui Agricultural University. He then earned his Ph.D. in Pathogeny Biology (2009–2014) from the same institute under the China CDC, equipping him with a deep scientific foundation to drive impactful research.

🧪 Experience

Currently the Senior Technologist and Director at Peking University Shougang Hospital (since 2016), Dr. Hu has also held vital roles such as Postdoctoral Fellow in Molecular Epidemiology at the China CDC (2014–2016) and Associate Senior Technologist at Peking University International Hospital (2014). From 2004 to 2014, he served as Deputy Department Director of the Microbiology Lab at Anhui CDC, where he led several high-level surveillance and diagnostic programs across China.

🔬 Research Interests On Medicine and Health Sciences

Dr. Hu’s research passion lies at the intersection of pathogenic biology and molecular biology. He is particularly focused on Helicobacter pylori infections, gut microbiota, antimicrobial resistance, and the genomic characterization of emerging pathogens. His studies contribute valuable insight into immune mechanisms, pathogen identification, and microbiome-related diseases.

🏆 Awards

While specific awards are not listed in the provided CV, Dr. Hu’s consistent corresponding authorship and leadership in high-impact international publications indicate significant professional recognition. His role in directing laboratory operations at a top-tier hospital and publishing in top Q1 journals further reflects his prestige and contributions to global health science.

📚 Publications

Below are key publications from the past 5 years, with hyperlinks, journal names, years, and citation roles:

  1. Isolation of Fluconazole-Resistant South Asian Clade Candida auris in Beijing, China, American Journal of Tropical Medicine and Hygiene, 2025 – Corresponding Author

  2. Influence of Helicobacter pylori on composition and function of gastric microbiota in patients with chronic non-atrophic gastritis, Heliyon, 2024 – Corresponding Author

  3. The role of toll-like receptors in immune tolerance induced by Helicobacter pylori infection, Helicobacter, 2023 – Corresponding Author

  4. Comparative analysis of the gut microbiota of wild adult rats from nine district areas in Hainan, China, World Journal of Gastroenterology, 2023 – Corresponding Author

  5. Ultra-efficient multiple cross displacement amplification-lateral flow biosensor for serogroup identification of prevalent Neisseria meningitidis, Analytical Biochemistry, 2022 – Corresponding Author

  6. Simultaneous detection of Streptococcus pneumoniae… using multiple cross displacement amplification, FEMS Microbiology Letters, 2021 – Corresponding Author

  7. Hemolysin BL from Bacillus toyonensis BV-17 induces antitumor activity both in vitro and in vivo, Gut Microbes, 2020 – Co-First Author

  8. Genomic analysis of Helicobacter himalayensis sp. nov. isolated from Marmota himalayana, BMC Genomics, 2020 – First Author

  9. Alteration of gut microbiota in type 2 diabetes complicated with cholelithiasis patients, Chinese Medical Journal, 2022 – Corresponding Author

✅ Conclusion

🎖️ Dr. Shoukui Hu is a pioneering clinical researcher and laboratory expert whose work spans epidemiological surveillance, diagnostic innovation, and microbiome science. With a sustained record of leadership, publication, and mentorship, he exemplifies the qualities of a Best Researcher Award nominee. His scholarly output and translational impact make him a key contributor to advancing infectious disease control and laboratory science in China and beyond.